Department of Epidemiology
Learn how we advance public health globally by researching the frequency, distribution, and causes of human disease, and shaping health policies and practices.
677 Huntington Avenue
Kresge, 9th Floor,
Boston, MA 02115
News
-
Omicron’s ‘milder’ severity likely due to population immunity
The SARS-CoV-2 Omicron variant’s “milder” outcomes are likely due to more population immunity compared to earlier waves of the pandemic, rather than the virus’s properties.
-
Epstein-Barr virus may be leading cause of multiple sclerosis
Multiple sclerosis is likely caused by infection with the Epstein-Barr virus, according to a new Harvard Chan School study.
-
Pedagogy Fellows program enhances teaching, learning
Under Harvard Chan School’s Pedagogy Fellows program, a small group of doctoral students and postdocs helps strengthen educational activities across courses, degree programs, and departments.
-
Coronavirus (COVID-19): Press Conference with Joseph Allen, 12/14/21
You’re listening to a press conference from the Harvard T.H. Chan School of Public Health with Joseph Allen, associate professor of Exposure Assessment Science and director of the Healthy Buildings…
-
Coronavirus Press Conference with Rebecca Weintraub, 12/09/21
You’re listening to a press conference from the Harvard T.H. Chan School of Public Health with Rebecca Weintraub, director of vaccine delivery at Ariadne Labs. This call was recorded at…
-
Coronavirus (COVID-19) Press Conference with Stephen Kissler, 12/07/21
You’re listening to a press conference from the Harvard T.H. Chan School of Public Health with Stephen Kissler, research fellow in the Department of Immunology and Infectious Diseases. This call…
-
Coronavirus (COVID-19) Press Conference with Sikhulile Moyo, Roger Shapiro and Joseph Makhema, 12/03/21
You’re listening to a press conference from the Harvard T.H. Chan School of Public Health with Sikhulile Moyo, laboratory director for the Botswana Harvard HIV Reference Laboratory in Gaborone, Botswana,…
-
Moderna vaccine slightly more effective than Pfizer vaccine in preventing COVID-19 infection, hospitalization, and death
Compared with the Pfizer COVID-19 vaccine, the Moderna COVID-19 vaccine has a slightly lower risk of COVID-19 outcomes, including hospitalization and death.
-
Breakthrough SARS-CoV-2 cases clear more quickly, less likely to spread infection over time
People who are vaccinated for SARS-CoV-2 but get breakthrough infections may be less likely to spread the virus because they shed it for a shorter period than unvaccinated people who are infected, according a new study led by Harvard Chan School.
-
Delta-like SARS-CoV-2 variants are most likely to increase pandemic severity
Delta-like SARS-CoV-2 variants are most likely to increase pandemic severity, according to a new study.
